The associated study on apolipoprotein A5 gene polymorphisms with carotid artherosclerosis in patients with cerebral infartion

Chinese Journal of Medical Genetics

Volumn 25, Issue 3, 2008, Pages 284-288

  Zhang, Kui ^a   Qui, Fang ^a   Li, Lei ^a   Gu, Guang Yu ^a   Tao, Yue ^a   Wang, Li ^a   Luo, Xun Yang ^a   Xia, Yong Quan ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Apolipoprotein A5; Cerebral infarction; Genetics polymorphism; Haplotype

Indexed keywords

APOLIPOPROTEIN A5; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; CAROTID ARTERY; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; APOLIPOPROTEINS A; CAROTID ARTERY DISEASES; CEREBRAL INFARCTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 46749083032     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Tanne D, Koren-Morag N, Graff E, et al. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the bezafibrate infarction prevention (bip) registry: high triglycerides constitute an independent risk factor. Circulation, 2001, 104:2892-2897.
2. Pikija S, Milevcic D, Trkulja V, et al. Higher serum triglyceride level in patients with acute ischemic stroke is associated with lower infarct volume on CT brain scans. Eur Neurol, 2006, 55:89-92.
3. Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study. BMJ, 1994, 309:11-15.
4. Li J, Xu HW, Zhu XY. Association of apoA5 gene polymorphism with levels of lipids and the rosclerotic cerebral infarction in Chinese. Chin J Med Cenet, 2007, 24:576-578.
5. Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science, 2001, 294:169-173.
6. van der Vilet HN, Sammels MG, Leegwater AC, et al. apolipoproteinA V : a novel apolipoprotein associated with a nearly phase of liver regeneration. J Biol Chem, 2001, 276:44512-44520.
7. Pennacchio LA, Olivier M, Hubacek JA, et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet, 2002, 11:3031-3038.
8. Hubacek J, Skodova Z, Adamkova V, et al. The influence of APOA5 polymorphisms (T -1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet, 2004, 65:126-130.
9. Liu H, Zhang S, Lin J, et al. Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism, 2005, 54:568-572.
10. Yamada Y, Kato K, Hibino T, et al. Prediction of genetic risk for metabolic syndrome. Atherosclerosis, 2007, 191:298-304.
11. Hsu LA, Ko YL, Chang CJ, et al. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis, 2006, 185:143-149.
12. Narvaez R, Yang Y, Nakanishi Y, et al. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the central valley of Costa Rica. J Lipid Res, 2005, 46:2605-2613.
13. Hubáček JA, Adámková V,češka R, et al. New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels. Physiol Res, 2004, 53:225-228.